Patents by Inventor David TABOR

David TABOR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230201331
    Abstract: The invention relates to A composition comprising a viral vector, wherein the viral vector is an adenovirus based vector, the viral vector comprising nucleic acid having a polynucleotide sequence encoding a polypeptide, said polypeptide having an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 1, characterised in that said polypeptide comprises the following substitutions relative to SEQ ID NO: 1: L18F, D80A, G215D, L242 ?, A243 ?, L244 ?, K417N, E484K, N501Y, D614G; and A701V. The invention also related to uses and methods.
    Type: Application
    Filed: June 7, 2022
    Publication date: June 29, 2023
    Applicant: Astrazeneca UK Limited
    Inventors: Helen BRIGHT, David TABOR